Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/17/1995WO1995021842A1 Heterocyclic compounds and their preparation and use
08/17/1995WO1995021840A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
08/17/1995WO1995021839A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
08/17/1995WO1995021838A1 Pyridyl imidazole derivatives and processes for the preparation thereof
08/17/1995WO1995021836A1 5-heteroarylindole derivatives as benzodiazepine receptor site agonists and antagonists
08/17/1995WO1995021832A1 Pharmaceutical piperazine compounds
08/17/1995WO1995021829A1 Pharmaceutical piperazine compounds
08/17/1995WO1995021827A1 Novel aconitine-like compound and antipyretic analgesic anti-inflammatory agent
08/17/1995WO1995021826A1 Antimalarial korupensamines and pharmaceutical compositions and medical uses thereof
08/17/1995WO1995021822A1 Pyridinium compounds
08/17/1995WO1995021821A1 New compounds with analgesic and local anaesthetic effect
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021817A1 Substituted spiro compounds for the treatment of inflammation
08/17/1995WO1995021813A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995WO1995021811A1 Novel benzylaminoethoxybenzene derivative, process for producing the same, and use thereof
08/17/1995WO1995021620A1 Inhibitors of cell-mediated disorders
08/17/1995WO1995021619A1 Compositions and methods for inhibiting microbial binding to surfaces
08/17/1995WO1995021618A1 Immunomodulation using nkr-p1, cd69 and ligands therefor
08/17/1995WO1995021617A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995WO1995021616A1 Naphthylisoquinoline alkaloids, pharmaceutical compositions containing them and their use for the treatment of malaria
08/17/1995WO1995021615A1 Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021612A2 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995WO1995021611A2 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995WO1995021609A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995WO1995021608A1 Use of insulin sensitisers for treating renal diseases
08/17/1995WO1995014465A3 Methods for amelioration of immunodeficiency virus induced neurodegeneration by covering nitric oxide or superoxide concentration
08/17/1995DE4404728A1 1-(2'-Hydroxy- und 2'-Sulfatoalkyl)glykoside 1- (2'-hydroxy and 2'-sulfatoalkyl) glycosides
08/17/1995DE4404399A1 Medicament contg. tiaprofenic acid enantiomer(s)
08/17/1995CA2185683A1 Monoclonal antibodies specific to vegf receptors and uses thereof
08/17/1995CA2183231A1 Androstanes and pregnanes for allosteric modulation of gaba receptor
08/17/1995CA2183154A1 Non-pathogenic strains of hiv-1
08/17/1995CA2183084A1 5-heteroarylindole derivatives
08/17/1995CA2183077A1 Cyclohexane derivatives as voltage-gated potassium channel blockers
08/17/1995CA2183069A1 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin
08/17/1995CA2182986A1 Use of insulin sensitisers for treating renal diseases
08/17/1995CA2182960A1 Texaphyrin metal complexes having improved functionalization
08/17/1995CA2182957A1 Heterocyclic compounds and their preparation and use
08/17/1995CA2182950A1 Substituted spiro compounds for the treatment of inflammation
08/17/1995CA2182877A1 Pharmaceutical piperazine compounds
08/17/1995CA2182876A1 Pharmaceutical piperazine compounds
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995CA2182680A1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
08/17/1995CA2182118A1 Nucleic acid-containing composition, its preparation and use
08/17/1995CA2181986A1 Carbamoylmethylurea derivatives
08/17/1995CA2181461A1 Treatment of normotensive glaucoma with angiotensin ii antagonists
08/17/1995CA2181068A1 New compounds with analgesic and local anaesthetic effect
08/17/1995CA2160019A1 Novel benzylaminoethoxybenzene derivatives, production thereof and use thereof
08/17/1995CA2142556A1 Substituted cyclohexanol esters, their use for treating diseases, and pharmaceutical preparations
08/17/1995CA2142535A1 1-[2-(1h-inden-3-yl)ethyl]-4- (naphth-1-yl)piperazine derivatives, their preparation and their application in therapeutics
08/17/1995CA2141506A1 Cosmetic or pharmaceutical compositions containing liposomes
08/16/1995EP0667351A1 Compound uch9
08/16/1995EP0667349A1 Depression remedy
08/16/1995EP0667348A1 Process for the preparation of nevirapine
08/16/1995EP0667347A1 Beta-carboline thromboxane synthase inhibitors
08/16/1995EP0667346A2 Azole antifungal agents, process for the preparation there of and intermediates
08/16/1995EP0667345A1 1-Benzyl-3-(substituted aryl)-condensed pyrazole derivatives as inhibitors of platelet aggregation
08/16/1995EP0667344A1 3-acylamino-5-(polysubstituted phenyl)-1,4-benzodiazepin-2-ones useful as CCK-receptor agonists
08/16/1995EP0667342A1 Substituted Arylureas and their use as anti-atheriosclerotic compounds
08/16/1995EP0667341A1 4-Amino-1-piperidylbenzoylguanidines as Na+/H+ antiporter inhibitors
08/16/1995EP0667340A1 Isatine derivates, their preparation and their use as excitatory amino acid receptor antagonist
08/16/1995EP0667166A1 Emulsion based on 1-alpha,24-dihydroxy-vitamine d3
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
08/16/1995EP0667161A1 Delayed release dosage form comprising clindamycin palmitate
08/16/1995EP0667160A2 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
08/16/1995EP0667159A2 Concentrated injectable solution of alcaline metal salts of reduced folates
08/16/1995EP0667158A1 Platelet aggregation inhibitor
08/16/1995EP0667157A1 Circulatory disturbance ameliorant
08/16/1995EP0667156A1 Ophthalmic composition containing a 1,5-benzoxathiepine derivative for treating glaucoma
08/16/1995EP0667155A1 Tablets containing thioctic acid with a specified size
08/16/1995EP0667154A1 Use of flavolignans as adjuvants in the therapy of tumors
08/16/1995EP0667153A1 Method of manufacturing composition for solid medicine
08/16/1995EP0667152A1 Oral use of calcium formate for the treatment of calcium deficiency in animals
08/16/1995EP0667151A1 Oral drug formulation containing diclofenac Sodium
08/16/1995EP0667150A1 Venlamafaxine and its analogues for inducing cognition enhancement
08/16/1995EP0667149A1 Ibuprofen based effervescent composition
08/16/1995EP0667145A1 Stabilized cosmetic or dermatologic composition containing several precursors of a same active agent
08/16/1995EP0667107A1 Bifidobacterium growth promoter
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666923A1 Targeted delivery of poly- or oligonucleotides to cells
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666862A1 6-(substituted methylene) penems and intermediates
08/16/1995EP0666861A1 Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
08/16/1995EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
08/16/1995EP0666858A1 5-arylindole derivatives and their use as serotonin (5-ht 1?) agonists
08/16/1995EP0666857A1 Method for preparing taxane derivatives
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995EP0666853A1 Antimicrobial 5-hydrazino-quinolone derivatives
08/16/1995EP0666851A1 Substituted phthalazinones as nerotensin antagonists
08/16/1995EP0666850A1 1,2,3,5,6,7,8,8a-OCTAHYDRO-5,5,8a-TRIMETHYL-(8a-g(b))-6-ISOQUINOLINEAMINE DERIVATIVES, PREPARATION METHOD THEREFOR AND THERAPEUTICAL USE THEREOF.
08/16/1995EP0666849A1 Aryl and heteroarylmethoxyphenyl inhibitors of leukotriene biosynthesis
08/16/1995EP0666847A1 Tryptamine analogs with 5-ht1d selectivity
08/16/1995EP0666846A1 New substituted azetidinones as anti-inflammatory and antidegenerative agents
08/16/1995EP0666845A1 High purity beta-carotene
08/16/1995EP0666844A1 Inhibitors of farnesyl-protein transferase
08/16/1995EP0666843A1 Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
08/16/1995EP0666842A1 Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
08/16/1995EP0666753A1 Method for the treatment of the complications and pathology of diabetes
08/16/1995EP0666749A1 ENANTIOMERICALLY PURE beta-D-DIOXOLANE NUCLEOSIDES WITH SELECTIVE ANTI-HEPATITIS B VIRUS ACTIVITY
1 ... 6992 6993 6994 6995 6996 6997 6998 6999 7000 7001 7002 7003 7004 7005 7006 7007 7008 7009 7010 7011 7012 ... 7860